Taishi Nakamura

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita et al. · Acta Neuropathologica Communications · 2016 · 265 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Recurrent mutations of <scp><i>CD79B</i></scp> and <scp><i>MYD88</i></scp> are the hallmark of primary central nervous system lymphomas

Taishi Nakamura, Kensuke Tateishi, T. Niwa et al. · Neuropathology and Applied Neurobiology · 2015 · 223 citations

Medicine, Molecular Genetics, Oncology +17

Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors

Kohei Fukuoka, Yonehiro Kanemura, Tomoko Shofuda et al. · Acta Neuropathologica Communications · 2018 · 148 citations · Full text

Medicine, Oncology, Pathology +17

Revisiting <scp><i>TP</i></scp><i>53</i> Mutations and Immunohistochemistry—A Comparative Study in 157 Diffuse Gliomas

Hirokazu Takami, Akihiko Yoshida, Shintaro Fukushima et al. · Brain Pathology · 2014 · 146 citations · Full text

Medicine, Oncology, Pathology +17

Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT Consortium

Hirokazu Takami, Kohei Fukuoka, Shintaro Fukushima et al. · Neuro-Oncology · 2019 · 117 citations · Full text

Veterinary Medicine, Oncology, Pathology +13